When a young psychiatrist walked into Washington DC’s Department of Corrections in 1968, he had a straightforward goal: use medicine to reduce crime. Inspired by his heroes John F. Kennedy and Martin Luther King Jr., Dr Robert L. DuPont sought to apply public health principles to work directly with convicted criminals. What he discovered there would reshape American approaches to substance abuse for generations to come.
In August 1969, with a handful of college students on summer break, DuPont’s team tested the urine of every man entering DC Jail. The results were shocking: 44 percent tested positive for heroin. Further analysis revealed that the year individuals first used heroin traced the onset of an epidemic fuelling Washington’s escalating crime wave. These findings, published in the prestigious New England Journal of Medicine, sparked a radical idea: what if treating addiction could prevent crime more effectively than punishment alone? The insight launched one of the most influential, and at times controversial, careers in addiction medicine.
From Washington’s Streets to the White House
DuPont’s response to the DC heroin crisis was swift and innovative. Under the mentorship of methadone pioneers Vincent Dole and Marie Nyswander, along with Jerome Jaffe, DuPont completed a crash course in addiction treatment. On 15 September 1969, he launched the city’s first methadone programme with just 25 prisoners on parole. Within a year, Mayor Walter Washington appointed him to lead the Narcotics Treatment Administration (NTA), which rapidly scaled to treat over 15,000 heroin-addicted residents across 20 treatment centres with a staff of more than 400.
The NTA pioneered a multimodality approach, offering both methadone maintenance and drug-free treatment options, allowing patients to choose the path that worked best for them. The results were dramatic: crime rates in Washington dropped by 50 percent over three years. Patients in treatment showed decreased heroin use, fewer arrests, and increased employment. The programme became widely recognised as the nation’s largest and most successful city-operated addiction treatment initiative of its time.
This visible success caught federal attention at precisely the moment heroin became a national emergency. In 1973, President Richard Nixon appointed DuPont as director of the White House Special Action Office for Drug Abuse Prevention, America’s second “drug czar”, whilst simultaneously naming him founding director of the National Institute on Drug Abuse (NIDA). He continued in these roles under President Gerald Ford, becoming an addiction treatment pioneer who helped institutionalise a balanced federal strategy combining law enforcement with major investments in treatment, prevention, and research.
Building America’s Addiction Treatment Infrastructure
As both drug czar and NIDA director, DuPont helped create the demand-reduction infrastructure that still shapes U.S. drug policy today. His leadership coincided with the rapid professionalisation of addiction treatment, including the spread of multimodality systems offering both methadone and drug-free options. He championed universal drug testing of criminal defendants, pioneering approaches that became models for Treatment Alternatives to Street Crime (TASC) and later drug courts.
DuPont’s time at NIDA was marked by remarkable productivity. The agency published over 200 professional papers during his first three years, documenting the effectiveness of large-scale treatment interventions. His work helped demonstrate that successful heroin addiction treatment not only helped individuals but also benefited entire communities through reduced crime rates, a finding that fundamentally shifted federal drug policy toward a more balanced approach.
After leaving government in 1978, DuPont founded the non-profit Institute for Behavior and Health (IBH), continuing his mission to develop strategies addressing illegal drug use. He also co-founded consulting firm Bensinger, DuPont & Associates, became a clinical professor of psychiatry at Georgetown University, and helped establish the Anxiety Disorders Association of America.
The “Selfish Brain” and Understanding Addiction
DuPont’s philosophy on addiction crystallised in his influential books, particularly “The Selfish Brain: Learning from Addiction,” first published in 1997 and updated in 2000. The book presents addiction as a chronic brain disease, exploring why the brain is so vulnerable to alcohol and other drugs, and how addiction reverberates through families, cultures, and history. Written in accessible language, it examines the biological roots of addiction and the role of denial in perpetuating destructive habits.
In “The Selfish Brain,” DuPont advocates for what he terms “tough-love” measures to help individuals break free from addiction’s grip. He particularly champions 12-step programmes like Alcoholics Anonymous and Narcotics Anonymous, which he has described as “the secret weapons in the war against drugs.” His view has evolved over decades: whilst he initially saw addiction treatment as a limited episode, he now regards it as a brief but potentially life-saving learning opportunity that introduces patients to lifelong recovery support through 12-step fellowships.
His 2018 book, “Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic,” further develops these themes, framing addiction as a form of enslavement that requires both individual commitment and societal support to overcome.
The “One Choice” Philosophy and Youth Prevention
Over recent decades, DuPont has increasingly emphasised primary prevention, particularly for adolescents. As an addiction treatment pioneer, he developed the “One Choice” message for young people: complete abstinence from alcohol, tobacco, and marijuana during adolescence, grounded in neurodevelopmental research on the vulnerable adolescent brain.
DuPont’s work demonstrates that delaying or preventing early substance use dramatically reduces lifetime addiction risk. He has examined the impacts of cannabis legalisation, noting concerns about normalisation and its effects on young people. His stance links directly to his early experience with heroin-using offenders: robust prevention, clear health standards, and evidence-based approaches remain essential components of both public health and public safety.
Long-Term Recovery and Lasting Impact
Throughout his career, DuPont has framed addiction as a chronic brain disease requiring long-term management. In his books “The Selfish Brain” and “Chemical Slavery,” he argued that policy and clinical systems should measure success by sustained abstinence over years, not short treatment episodes.
His nearly five-decade journey with IBH reflects a sustained commitment to supporting health and wellness across the continuum of care. The organisation has elevated youth substance use prevention as its top priority, recognising substance use disorder as a paediatric-onset condition requiring a public health approach. By helping communities reach young people, parents, and caregivers with information needed to support healthy choices, this work aims to dramatically reduce the future prevalence of addiction.
Beyond his work in substance abuse, DuPont has made significant contributions to the understanding and treatment of anxiety disorders. In 1980, he co-founded the Anxiety Disorders Association of America (ADAA), helping to transform these conditions from overlooked “neuroses” into recognised, treatable disorders. His clinical work and research on panic disorder, agoraphobia, and other anxiety conditions has influenced treatment approaches worldwide, and he has authored numerous books on anxiety for both professionals and families.
Pioneering the Physician Health Program Model
One of DuPont’s most significant contributions to addiction treatment came through his research on Physician Health Programs (PHPs), state-based programmes designed to help doctors struggling with substance use disorders. Beginning in 2005, DuPont led groundbreaking research that followed 904 physicians across 16 states for five years or longer, documenting remarkable success rates.
The PHP model combines intensive treatment with long-term monitoring, frequent random drug testing, and meaningful consequences for relapse, including potential loss of medical licence. The results were striking: 78 percent of physicians had no positive drug tests over five years, 14 percent had one positive test, and only 8 percent had two or more. This success rate far exceeded typical addiction treatment outcomes.
What made DuPont particularly excited about this research was its implications for all addiction treatment, not just physicians. He has advocated for applying the PHP model’s core principles, swift consequences, long-term monitoring, and five-year recovery goals, to other populations. Similar approaches have shown success with diverse groups, from airline pilots to criminal offenders, suggesting that the model’s effectiveness extends well beyond the medical profession.
A Consistent Vision Across Five Decades
From DC prisons to the White House to non-profit leadership, DuPont’s core message as an addiction treatment pioneer has remained remarkably consistent: addiction is preventable and treatable, but prevention must start early and treatment systems must support stable, long-term recovery. His emphasis on the developing brain, the importance of delaying substance use onset, and the value of sustained recovery outcomes continues to influence policy discussions today.
DuPont’s career reflects an unwavering commitment to reducing both addiction and crime through evidence-based approaches. His early goal of helping criminals by addressing their addiction has expanded into a comprehensive public health philosophy that views crime reduction and addiction treatment as inseparable objectives. As he has noted, reducing crime is not merely a criminal justice concern but a major public health objective, akin to reducing drink-driving, benefiting both communities and individuals trapped in destructive lifestyles.
Throughout his career spanning over 50 years, DuPont has published more than 400 professional articles and 15 books on addiction, anxiety disorders, and public health. His other works include “A Bridge to Recovery: An Introduction to Twelve-Step Programs” and “Getting Tough on Gateway Drugs: A Guide for the Family.” His influence extends beyond academic circles through his ongoing work with organisations such as the National Association of Drug Court Professionals and the American Council on Science and Health. He has trained countless professionals in addiction treatment, helping to establish the comprehensive training programmes that became standard for doctors, nurses, and counsellors working in the field.
In 2025, colleagues and friends gathered in Washington DC to honour DuPont for his decades of national leadership. Now 89, his vision of a culture that supports health and wellness, particularly for young people at greatest risk, continues to shape conversations about how societies can best address substance use challenges. After more than 50 years of practice, DuPont retired from clinical psychiatry in 2024, though he remains active through IBH and continues to advocate for evidence-based approaches to both addiction and anxiety disorders.
Sources and Further Reading
Primary Sources and Official Materials
- Institute for Behavior and Health Leadership Page
- One Choice Prevention: Robert L. DuPont
- Congressional Testimony and Publications (PDF)
Academic Research and Journal Articles
- DuPont, R.L., McLellan, A.T., White, W.L., Merlo, L.J., & Gold, M.S. (2009). “Setting the Standard for Recovery: Physicians’ Health Programs.” Journal of Substance Abuse Treatment, 36(2), 159-171. PubMed | ScienceDirect
- DuPont, R.L., & Katon, R.N. (1971). “Development of a Heroin Addiction Treatment Program: Effect on Urban Crime.” Journal of the American Medical Association, 216, 1320-1324.
- DuPont, R.L., & Greene, M.H. (1973). “The Dynamics of a Heroin Addiction Epidemic.” Science, 181, 716-722. Science.org | PubMed
- ADAA 40th Anniversary Reflections (PDF)
Books by Robert L. DuPont
- DuPont, R.L. (2018). Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic. Center City, MN: Hazelden.
- DuPont, R.L. (2000). The Selfish Brain: Learning from Addiction (Revised and updated). Center City, MN: Hazelden.
- DuPont, R.L., Goldstein, A., & O’Donnel, J. (Eds.) (1978). Handbook on Drug Abuse. Rockville, MD: National Institute on Drug Abuse.

Leave a Reply